Schedule 13G ownership disclosure
ETERNA THERAPEUTICS INC
Common Stock, par value $0.005 per share · CUSIP: 114082209
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- John D. Halpern
Shares: 5,971,830 · Class: 9.6%
- Katherine H. Halpern
Shares: 5,971,830 · Class: 9.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-073071
- Form type
- SCHEDULE 13G/A
- Filer
- Ernexa Therapeutics Inc.
- CIK
- CIK 748592
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership